通过不同的机制性途径,通过天然化合物对三阴性乳腺癌的治疗
Mohammed Kaleem1, Mandar Thool2, Nitin G Dumore1
1Department of Pharmacology, Dadasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, India.
Frontiers in genetics
|August 12, 2024
概括
三阴性乳腺癌 (TNBC) 是一种由表观遗传因素驱动的侵袭性癌症亚型. 本综述详细介绍了TNBC亚型,遗传链接,以及潜在管理的天然化合物.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 遗传学 遗传学 是一个
背景情况:
- 三阴性乳腺癌 (TNBC) 是最具攻击性的乳腺癌亚型.
- TNBC是由雌激素,孕激素和HER2受体的缺失所定义的,导致预后不佳.
- 遗传和表观遗传改变是TNBC发育,进展和转移的主要驱动因素.
研究的目的:
- 综合审查TNBC亚型及其相关表观遗传原因.
- 阐明TNBC的遗传情景,包括关键基因和信号通路.
- 探索自然化合物在TNBC管理中的治疗潜力.
主要方法:
- 对TNBC亚型的文献综述,重点关注诸如DNA甲基化和基因组修饰等表观遗传机制.
- 编译遗传关联,包括重要基因和信号通路,涉及到TNBC进展.
- 对天然化合物及其用于TNBC治疗的机制性途径的研究分析.
主要成果:
- 详细分类TNBC亚型及其特定表观遗传驱动因素.
- 对导致TNBC的遗传因素和信号通路进行了全面的测绘.
- 识别各种天然化合物及其在TNBC中的潜在治疗作用.
结论:
- 表观遗传失调是TNBC病原和转移的核心.
- 了解TNBC的遗传基础对于向治疗至关重要.
- 自然化合物为新型TNBC治疗策略提供了有希望的途径.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


